| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
James Buchanan Brady Foundation, Department of Surgery, Division of Urology and Department of Medicine, Division of Endocrinology and Metabolism, The New York Hospital/Cornell University Medical College New York, New York 10021
Address all correspondence and requests for reprints to: Dr. Julia Spencer, New York Hospital, Cornell Medical Center, James Buchanan Brady Foundation, Department of Surgery, Division of Urology, 525 East 68th Street, New York, New York 10021.
Abstract
The endocrine control of descent of the testis in mammalian species is poorly understood. The androgen dependency of testicular descent was studied in the rat using an antiandrogen (flutamide) and an inhibitor of the enzyme 5
-reductase (finasteride). Androgen receptor blockade inhibited testicular descent more effectively than inhibition of 5
-reductase activity. Moreover, its inhibitory effect was limited to the outgrowth phase of the gubernaculum testis, particularly the earliest stages of outgrowth. Gubernacular size was also significantly reduced in fetuses exposed to flutamide during the outgrowth period. In contrast, androgen receptor blockade or 5
-reductase inhibition applied after the initiation of gubernacular outgrowth or during the regression phase did not affect testicular descent. Successful inhibition of the development of epididymis and vas by prenatal flutamide did not correlate with ipsilateral testicular maldescent, suggesting that an intact epididymis is not required for descent of the testis. Plasma androgen assays confirmed significant inhibition of dihydrotestosterone formation in finasteride-treated rats. These data suggest that androgens, primarily testosterone, are required during the early phases of gubernacular outgrowth for subsequent successful completion of testicular descent.
Received February 25, 1991.
This article has been cited by other articles:
![]() |
A. J. Drake, S. van den Driesche, H. M. Scott, G. R. Hutchison, J. R. Seckl, and R. M. Sharpe Glucocorticoids Amplify Dibutyl Phthalate-Induced Disruption of Testosterone Production and Male Reproductive Development Endocrinology, November 1, 2009; 150(11): 5055 - 5064. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Johnson, S. M. McCahan, X. Si, L. Campion, R. Herrmann, and J. S. Barthold The orl Rat with Inherited Cryptorchidism Has Increased Susceptibility to the Testicular Effects of In Utero Dibutyl Phthalate Exposure Toxicol. Sci., October 1, 2008; 105(2): 360 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Foresta, D. Zuccarello, A. Garolla, and A. Ferlin Role of Hormones, Genes, and Environment in Human Cryptorchidism Endocr. Rev., August 1, 2008; 29(5): 560 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Barthold, S. M. Mccahan, A. V. Singh, T. B. Knudsen, X. Si, L. Campion, and R. E. Akins Altered Expression of Muscle- and Cytoskeleton-Related Genes in a Rat Strain With Inherited Cryptorchidism J Androl, May 1, 2008; 29(3): 352 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Willnow, A. Hammes, and S. Eaton Lipoproteins and their receptors in embryonic development: more than cholesterol clearance Development, September 15, 2007; 134(18): 3239 - 3249. [Abstract] [Full Text] [PDF] |
||||
![]() |
R P Amann and D N R Veeramachaneni Cryptorchidism in common eutherian mammals Reproduction, March 1, 2007; 133(3): 541 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Bowman, N. J. Barlow, K. J. Turner, D. G. Wallace, and P. M. D. Foster Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat Toxicol. Sci., August 1, 2003; 74(2): 393 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Thonneau, P. Candia, and R. Mieusset Cryptorchidism: Incidence, Risk Factors, and Potential Role of Environment; An Update J Androl, March 1, 2003; 24(2): 155 - 162. [Full Text] [PDF] |
||||
![]() |
J. M. A. Emmen, A. McLuskey, I. M. Adham, W. Engel, J. A. Grootegoed, and A. O. Brinkmann Hormonal Control of Gubernaculum Development during Testis Descent: Gubernaculum Outgrowth in Vitro Requires Both Insulin-Like Factor and Androgen Endocrinology, December 1, 2000; 141(12): 4720 - 4727. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Azziz, E. Carmina, and M. E. Sawaya Idiopathic Hirsutism Endocr. Rev., August 1, 2000; 21(4): 347 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Wolf, G. A. LeBlanc, J. S. Ostby, and L. E. Gray Jr. Characterization of the Period of Sensitivity of Fetal Male Sexual Development to Vinclozolin Toxicol. Sci., May 1, 2000; 55(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Schrader and G. M. Cooke Examination of Selected Food Additives and Organochlorine Food Contaminants for Androgenic Activity in Vitro Toxicol. Sci., February 1, 2000; 53(2): 278 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hutson, S. Hasthorpe, and C. F. Heyns Anatomical and Functional Aspects of Testicular Descent and Cryptorchidism Endocr. Rev., April 1, 1997; 18(2): 259 - 280. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |